QuidelOrtho Corporation (QDEL) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

16/25

Growth 4 Margin 2 Expansion 5 Platform 2 Financial 3

latest quarter score

Earnings Reports

16
QuidelOrtho (QDEL) Q2 2026: China Revenue Drops 23%, Underlying Core Grows 6% as Guidance Tightens
August 07, 2026
15
QuidelOrtho (QDEL) Q1 2026: $75M Guidance Cut as Respiratory and China Headwinds Hit, Margin Expansion Still in Play
June 17, 2026
13
QuidelOrtho (QDEL) Q2 2025: EBITDA Margin Expands 330bps as Cost Actions Offset COVID Slide
June 16, 2026
17
QuidelOrtho (QDEL) Q3 2025: $140M Cost Savings Drive 180bp Margin Expansion Amid Core Growth
June 16, 2026
19
QuidelOrtho (QDEL) Q4 2025: $140M Cost Savings Drive 240bp Margin Expansion, Cash Flow Path Still in Focus
June 15, 2026
24
QuidelOrtho (QDEL) Q1 2025: Tariff Headwind of $30–40M Fully Offset as Labs Drive 7% Growth
July 04, 2025

Browse all companies